IAP BIR DOMAIN BINDING COMPOUNDS

DISCLOSED HEREIN IS AN ISOMER, ENANTIOMER, DIASTEREOISOMER OR TAUTOMER OF A COMPOUND REPRESENTED BY FORMULA I: OR A PRODRUG, OR A PHARMACEUTICALLY ACCEPTABLE SALT, OR LABELED WITH A DETECTABLE LABEL OR AN AFFINITY TAG THEREOF; WHEREIN R1, R1a, R100, R100a, R2, R200, W, B, AND W1 ARE DEFINED HEREIN....

Full description

Saved in:
Bibliographic Details
Main Authors BOUDREAULT, ALAIN, JARVIS, SCOTT, BUREAU, PATRICK, LAURENT, ALAIN, JAQUITH, JAMES
Format Patent
LanguageEnglish
Published 13.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:DISCLOSED HEREIN IS AN ISOMER, ENANTIOMER, DIASTEREOISOMER OR TAUTOMER OF A COMPOUND REPRESENTED BY FORMULA I: OR A PRODRUG, OR A PHARMACEUTICALLY ACCEPTABLE SALT, OR LABELED WITH A DETECTABLE LABEL OR AN AFFINITY TAG THEREOF; WHEREIN R1, R1a, R100, R100a, R2, R200, W, B, AND W1 ARE DEFINED HEREIN. ALSO DISCLOSED ARE METHODS OF USING COMPOUNDS OF FORMULA I TO TREAT PROLIFERATIVE DISORDERS SUCH AS CANCER.
Bibliography:Application Number: MY2008PI04382